InsidersTradesSigma
Follow the 삼일제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 삼일제약 has recorded 9 insider filings. Market capitalisation: €137bn. The latest transaction was filed on 1 June 2026 (Purchase). Among the most active insiders: 허승범. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9 of 9 declarations
삼일제약 is a South Korean company operating in the healthcare and pharmaceutical sector. It is listed on the XKRX.